The anti-atelectasis factor considered in relation to Bisolvon and its metabolite VIII.
D000653:Amniotic Fluid / Q000187:drug effects / Q000378:metabolism; D000814:Aniline Compounds / Q000378:metabolism; D000818:Animals; D001964:Bromhexine / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D003514:Cyclohexylamines / Q000378:metabolism; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008168:Lung / Q000187:drug effects* / Q000378:metabolism; D008431:Maternal-Fetal Exchange; D051379:Mice; D010710:Phosphates / Q000378:metabolism; D010713:Phosphatidylcholines / Q000378:metabolism; D011247:Pregnancy; D011663:Pulmonary Surfactants / Q000378:metabolism*; D011817:Rabbits; D051381:Rats; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy / Q000378:metabolism; D013268:Stimulation, Chemical
D000814:Aniline Compounds; D003514:Cyclohexylamines; D010710:Phosphates; D010713:Phosphatidylcholines; D011663:Pulmonary Surfactants; D001964:Bromhexine